SEC Form 4 · accession 0001144204-18-003702
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jan 23, 2018
Accepted (ET)
Jan 25, 2018 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Jan 23, 2018 | S | 106,326 | $7.8246 | D | 9,195,475 | D | |
| Common StockF2,F3 | Jan 24, 2018 | S | 577,962 | $7.5156 | D | 8,617,513 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.75 to $8.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.675, inclusive.
- F3This Form 4 is being filed by Asia Pacific MedTech (BVI) Limited as the direct beneficial owner of the shares of Common Stock. Nana Gu is the indirect beneficial owner of the shares of Common Stock in her capacity as the sole director and sole shareholder of Asia Pacific MedTech (BVI) Limited.